Published Research July 11, 2024 The Importance of Clinical Trials in Cancer Care Clinical trials are pivotal in advancing cancer treatment and improving patient outcomes. They offer patients access to cutting-edge treatments while contributing valuable insights that drive the evolution of cancer care. This whitepaper examines clinical trials as a potential value lever within employer-sponsored health plans, highlighting their dual impact on enhancing cancer care and managing healthcare costs. Read More
Case Studies June 12, 2024 Navigating a diagnosis with a rare form of Alzheimer’s Facing a diagnosis of Alzheimer's disease at a young age can be shocking and frightening for patients and their families. James*, an active 50-year-old executive, began experiencing memory lapses, such as forgetting co-workers’ names and simple addresses. Seeking further assistance, James turned to PHM upon a family member's recommendation. Read More
Ask Our Experts June 12, 2024 Protecting yourself from tick-borne illnesses During the warm months of spring and summer, the looming threat of ticks becomes more palpable. While most people are aware of Lyme disease as the primary concern, ticks carry a staggering array of 13 other diseases. Read More
Ask Our Experts June 12, 2024 Exploring a rare form of Alzheimer’s disease affecting younger individuals Alzheimer’s disease, the most common form of dementia in the United States, affects millions of Americans, predominately striking after the age of 60. However, there is a lesser-known rare variant of Alzheimer’s called Posterior Cortical Atrophy (PCA) that makes up about 5% of cases. Read More
Ask Our Experts June 12, 2024 FDA approves the first treatment to reduce the severity of food allergy reactions For the first time, the FDA has approved a treatment to reduce the severity of dangerous allergic reactions due to accidental exposure to food allergens. Here’s what to know about this new tool to help manage food allergies. Read More
Case Studies May 22, 2024 Living and thriving as a cancer survivor Becky, a vibrant and active woman, faced a life-altering diagnosis of Stage IV lung cancer. Guided by PHM's Personal Care Team and the power of molecular profiling, Becky's treatment evolved based on her unique genetic markers, leading to remarkable progress. Read More
